The detection of antimitochondrial antibodies (AMAs) is an important c
riterion for the diagnosis of primary biliary cirrhosis (PBC). During
the last decade, the mitochondrial autoantigens have been cloned, sequ
enced, and identified as members of the 2-oxo-acid dehydrogenase pathw
ay, including the E2 subunits of pyruvate dehydrogenase (PDC-E2), bran
ched-chain 2-oxo-acid dehydrogenase (BCOADC-E2), and 2-oxo-glutarate d
ehydrogenase (OGDC-E2). We have developed a rapid and sensitive diagno
stic test for use in PBC based on a triple hybrid recombinant molecule
(r-MIT3) that contains the autoepitopes of PDC-E2, BCOADC-E2, and OGD
C-E2. To help understand the frequency and antigen specificity of AMAs
in an asymptomatic population and to identify patients with early dis
ease, we investigated the prevalence of AMA, by enzyme-linked immunoso
rbent assay (ELISA), in a cohort of 1,530 people from northern Italy.
Positive sera were further analyzed for immunoglobulin (Ig) isotypes,
subclasses, and epitopes of AMA by a combination of ELISA and immunobl
otting. In this cohort of 1,530 people, 9 (0.5%) reacted to r-MIT3 by
ELISA. Of the 9 reactive sera, 2 recognized PDC-E2, 2 of 9 recognized
BCOADC-E2, 1 of 9 recognized OGDC-E2, 2 of 9 recognized both PDC-E2 an
d BCOADC-E2, and 1 of 9 recognized PDC-E2 and OGDC-E2. AMA reactivity
was primarily IgM and IgA. Epitope mapping revealed an AMA pattern of
reactivity to PDC-E2 that differed from that found in patients with hi
stologically proven PBC in most of the sera. However, 1 sera of a 72-y
ear-old female with a normal alkaline phosphatase had an AMA profile i
dentical to typical PBC. After a variable follow-up period (8-14 month
s), sera from 8 of 9 of these people were re-obtained for AMA and rela
tive epitope mapping. Interestingly, the reactivity had a wider AMA pa
ttern than before.